Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Transplant Infusion of Allogeneic CD8 Memory T-Cells as Consolidative Therapy After Non-myeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Leukemia and Lymphoma

NCT02424968 is registered in ClinicalTrials.gov with Robert Lowsky as lead sponsor.

NCT NCT02424968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02424968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Transplant Infusion of Allogeneic CD8 Memory T-Cells as Consolidative Therapy After Non-myeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Leukemia and Lymphoma
Lead sponsor
Robert Lowsky
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2015
Completion date
April 30, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, b-cell non-hodgkin lymphoma, chronic lymphocytic leukemia, hodgkin lymphoma, myelodysplastic syndrome, myeloproliferative neoplasm, t-cell non-hodgkin lymphoma